Fundz
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Hikma Pharmaceuticals Appoints Rebecca Hall as Chief Financial Officer

PRIVATESep 24, 2026about 3 hours ago

Position

Chief Financial Officer

Company

Hikma Pharmaceuticals

Rebecca Hall
OhioManufacturingBiotechnologyHealth CarePharmaceutical

Description

Hikma Pharmaceuticals has announced the appointment of Rebecca Hall as its new chief financial officer and executive director. She is expected to officially join the leadership team in the first quarter of 2027.

Company Information

Company

Hikma Pharmaceuticals

Location

Ohio, United States

About

Hikma Pharmaceuticals is a leading player in the U.S. generic drug market. The company specializes in the manufacturing of complex generics, particularly sterile injectables, aimed at addressing the growing demand for oncology and chronic-care drugs. With a significant expansion in Ohio, Hikma aims to solidify its position by leveraging AI-driven private markets for funding. The company is focused on producing over 12 billion doses annually by 2030.

Fundz sees it the moment Hikma Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Hikma Pharmaceuticals's next move

Learn about Strategic plan

Hikma Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.